Ohio Issue 2 ballot initiative proponents overstate impact on EpiPen prices image

Politifact, October 13, 2017
Manuela Tobias, quoting Rachel E. Sachs (Academic Fellow Alumna)


Read the full article

From the article:

In addition to the Medicaid program, the state purchases drugs for state employees, prisons, and other state-run programs, but the campaign was unable to pin down the effect of the initiative on these groups. Dennis Willard, a campaign spokesman, said 4 million Ohioans would be affected, 2.8 million of whom are on Medicaid or CHIP.

Rachel Sachs, a professor at Washington University in St. Louis School of Law, told us that if the initiative worked (she identified various legal issues with it in a blog post), the biggest impact would be felt by state correctional systems, which go unmentioned in the ad.

Read more here!

fda health care finance health law policy pharmaceuticals rachel sachs regulation